Search

Your search keyword '"Benveniste O"' showing total 988 results

Search Constraints

Start Over You searched for: Author "Benveniste O" Remove constraint Author: "Benveniste O"
988 results on '"Benveniste O"'

Search Results

51. Long-Term Outcomes Among Participants in the WEGENT Trial of Remission-Maintenance Therapy for Granulomatosis With Polyangiitis (Wegenerʼs) or Microscopic Polyangiitis

52. Myositis-specific and myositis-associated autoantibodies predict trajectories of damage over time in idiopathic inflammatory myopathies

53. AUTOIMMUNE & INFLAMMATORY NMD

55. Phénotypes cliniques et pronostics associes aux anticorps anti-Ku déterminés par une analyse en clusters : une étude multicentrique de 154 patients

56. Facteurs de risque de mortalité des dermatomyosites associées à un cancer : une étude de cohorte rétrospective multicentrique de 73 patients

59. Spectre clinique et pronostic des connectivites à anti PM-Scl ; une étude multicentrique incluant 128 patients

61. Efficacy and safety of Bimagrumab in sporadic inclusion body myositis

67. POS0323 ANTI PM-SCL ASSOCIATED AUTO IMMUNE DISEASES: MULTICENTRIC COHORT OF 128 PATIENTS

70. IVIg increases interleukin-11 levels, which in turn contribute to increased platelets, VWF and FVIII in mice and humans

71. Facteurs prédictifs de formes rapidement progressives au cours des pneumopathies interstitielles diffuses associées à un anticorps anti-MDA5, en France

72. T1 mapping-derived signature of myocardial involvement in idiopathic inflammatory myopathy compared to acute viral myocarditis: a texture-based analysis

74. AUTOIMMUNE MYOPATHIES

75. AUTOIMMUNE MYOPATHIES

76. MUSCLE IMAGING – MRI

78. Phénotype et pronostic des atteintes systémiques induites sous inhibiteurs de check-points immunitaires

82. 2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria—methodological aspects

83. Cytosolic 5 '-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis

84. Myositis in patients with primary Sjögren’s syndrome: data from a French nationwide survey

85. Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial

86. Autoantibody testing in idiopathic inflammatory myopathies

87. Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial

90. P.07Severe axial and pelvifemoral muscle damage in immune-mediated necrotizing myopathy evaluated by whole-body MRI

94. P.08Interferon level assessed by ultrasensitive detection technology in myositis patients: a promising biomarker of disease activity in dermatomyositis and anti-synthetase syndrome

96. MRI – MUSCLE IMAGING

100. La biopsie cérébrale en médecine interne : un acte sûr et rentable

Catalog

Books, media, physical & digital resources